Follow
'Bayer’s chief executive has blamed an “old chemistry mindset” and a chronic lack of investment in research by his predecessors for a thin drug pipeline that has dragged down the group’s share price.'
https://www.ft.com/content/ffce99b0-7fd6-4b47-94f4-45d03cd68882
@cyrilpedia classic example - short term cost savings hurt in the long run and can't be turned around quiclky.